Faslodex (fulvestrant)

pCPA File Number: 20989
Negotiation Status:
Concluded without agreement
Indication(s):
Locally Advanced or Metastatic Breast Cancer
Sponsor/Manufacturer:
AstraZeneca Canada Inc.
CADTH Project Number:
pCODR 10110
pCPA Engagement Letter Issued:
Negotiation Process Concluded: